{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T01:04:35Z","timestamp":1790039075718,"version":"4.0.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,1,26]],"date-time":"2013-01-26T00:00:00Z","timestamp":1359158400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"},{"start":{"date-parts":[[2013,1,26]],"date-time":"2013-01-26T00:00:00Z","timestamp":1359158400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Biomed Semant"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Out-of-date or incomplete drug product labeling information may increase the risk of otherwise preventable adverse drug events. In recognition of these concerns, the United States Federal Drug Administration (FDA) requires drug product labels to include specific information. Unfortunately, several studies have found that drug product labeling fails to keep current with the scientific literature. We present a novel approach to addressing this issue. The primary goal of this novel approach is to better meet the information needs of persons who consult the drug product label for information on a drug\u2019s efficacy, effectiveness, and safety. Using FDA product label regulations as a guide, the approach links drug claims present in drug information sources available on the Semantic Web with specific product label sections. Here we report on pilot work that establishes the baseline performance characteristics of a proof-of-concept system implementing the novel approach. Claims from three drug information sources were linked to the\n                    <jats:italic>Clinical Studies<\/jats:italic>\n                    ,\n                    <jats:italic>Drug Interactions<\/jats:italic>\n                    , and\n                    <jats:italic>Clinical Pharmacology<\/jats:italic>\n                    sections of the labels for drug products that contain one of 29 psychotropic drugs. The resulting Linked Data set maps 409 efficacy\/effectiveness study results, 784 drug-drug interactions, and 112 metabolic pathway assertions derived from three clinically-oriented drug information sources (ClinicalTrials.gov, the National Drug File \u2013 Reference Terminology, and the Drug Interaction Knowledge Base) to the sections of 1,102 product labels. Proof-of-concept web pages were created for all 1,102 drug product labels that demonstrate one possible approach to presenting information that dynamically enhances drug product labeling. We found that approximately one in five efficacy\/effectiveness claims were relevant to the\n                    <jats:italic>Clinical Studies<\/jats:italic>\n                    section of a psychotropic drug product, with most relevant claims providing new information. We also identified several cases where all of the drug-drug interaction claims linked to the\n                    <jats:italic>Drug Interactions<\/jats:italic>\n                    section for a drug were potentially novel. The baseline performance characteristics of the proof-of-concept will enable further technical and user-centered research on robust methods for scaling the approach to the many thousands of product labels currently on the market.\n                  <\/jats:p>","DOI":"10.1186\/2041-1480-4-5","type":"journal-article","created":{"date-parts":[[2013,1,26]],"date-time":"2013-01-26T10:14:15Z","timestamp":1359195255000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Dynamic enhancement of drug product labels to support drug safety, efficacy, and effectiveness"],"prefix":"10.1186","volume":"4","author":[{"given":"Richard D","family":"Boyce","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R","family":"Horn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oktie","family":"Hassanzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"De Waard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jodi","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne S","family":"Luciano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majid","family":"Rastegar-Mojarad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Liakata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,1,26]]},"reference":[{"issue":"3","key":"127_CR1","doi-asserted-by":"publisher","first-page":"161","DOI":"10.2165\/00003088-200241030-00001","volume":"41","author":"PJ Marroum","year":"2002","unstructured":"Marroum PJ, Gobburu J: The product label: how pharmacokinetics and pharmacodynamics reach the prescriber. Clin Pharmacokinetics. 2002, 41 (3): 161-169. 10.2165\/00003088-200241030-00001. [http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11929317]. [PMID: 11929317]","journal-title":"Clin Pharmacokinetics"},{"issue":"6","key":"127_CR2","doi-asserted-by":"publisher","first-page":"525","DOI":"10.2165\/00002018-200831060-00007","volume":"31","author":"Y Ko","year":"2008","unstructured":"Ko Y, Malone D, Skrepnek G, Armstrong E, Murphy J, Abarca J, Rehfeld R, Reel S, Woosley R: Prescribers\u2019 knowledge of and sources of information for potential drug-drug interactions: a postal survey of US prescribers. Drug Safety: An Int J Med Toxicol Drug Experience. 2008, 31 (6): 525-536. 10.2165\/00002018-200831060-00007. [http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18484786]. [PMID: 18484786]","journal-title":"Drug Safety: An Int J Med Toxicol Drug Experience"},{"key":"127_CR3","volume-title":"CFR - Code of Federal Regulations Title 21","author":"FDA","year":"2011","unstructured":"FDA: CFR - Code of Federal Regulations Title 21. 2011, [http:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfcfr\/CFRSearch.cfm?fr=201.57]. [Last Accessed: 03\/23\/2012]"},{"issue":"2","key":"127_CR4","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.amjopharm.2012.01.001","volume":"10","author":"RD Boyce","year":"2012","unstructured":"Boyce RD, Handler SM, Karp JF, Hanlon JT: Age-related changes in antidepressant pharmacokinetics and potential drug-drug interactions: a comparison of evidence-based literature and package insert information. Am J Geriatric Pharmacother. 2012, 10 (2): 139-150. 10.1016\/j.amjopharm.2012.01.001. [PMID: 22285509]","journal-title":"Am J Geriatric Pharmacother"},{"issue":"5","key":"127_CR5","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1111\/j.1532-5415.2005.53273.x","volume":"53","author":"KL Steinmetz","year":"2005","unstructured":"Steinmetz KL, Coley KC, Pollock BG: Assessment of geriatric information on the drug label for commonly prescribed drugs in older people. J Am Geriatrics Soc. 2005, 53 (5): 891-894. 10.1111\/j.1532-5415.2005.53273.x. [http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15877571]. [PMID: 15877571]","journal-title":"J Am Geriatrics Soc"},{"key":"127_CR6","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.clinthera.2011.01.021","volume":"33","author":"L Hines","year":"2011","unstructured":"Hines L, Ceron-Cabrera D, Romero K, Anthony M, Woosley R, Armstrong E, Malone D: Evaluation of warfarin drug interaction listings in US product information for warfarin and interacting drugs. Clin Ther. 2011, 33: 36-45. 10.1016\/j.clinthera.2011.01.021. [http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21397772]. [PMID: 21397772]","journal-title":"Clin Ther"},{"issue":"2","key":"127_CR7","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.jbi.2009.11.001","volume":"43","author":"C Blake","year":"2010","unstructured":"Blake C: Beyond genes, proteins, and abstracts: Identifying scientific claims from full-text biomedical articles. J Biomed Informatics. 2010, 43 (2): 173-189. 10.1016\/j.jbi.2009.11.001.","journal-title":"J Biomed Informatics"},{"issue":"5","key":"127_CR8","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.jbi.2008.04.010","volume":"41","author":"P Ciccarese","year":"2008","unstructured":"Ciccarese P, Wu E, Wong GT, Ocana M, Kinoshita J, Ruttenberg A, Clark T: The SWAN biomedical discourse ontology. J Biomed Informatics. 2008, 41 (5): 739-751. 10.1016\/j.jbi.2008.04.010.","journal-title":"J Biomed Informatics"},{"key":"127_CR9","volume-title":"Proceedings of the Workshop on Semantic Web Applications in Scientific Discourse (SWASD 2009), co-located with the 8th International Semantic Web Conference (ISWC-2009)","author":"A de Waard","year":"2009","unstructured":"de Waard A, Buckingham Shum S, Carusi A, Park J, Samwald M, S\u00e1ndor A: Hypotheses, evidence and relationships: The HypER approach for representing scientific knowledge claims. Proceedings of the Workshop on Semantic Web Applications in Scientific Discourse (SWASD 2009), co-located with the 8th International Semantic Web Conference (ISWC-2009). 2009"},{"key":"127_CR10","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/978-3-540-76298-0_15","volume-title":"The Semantic Web: Research and Applications","author":"T Groza","year":"2007","unstructured":"Groza T, M\u00f6ller K, Handschuh S, Trif D, Decker S: SALT: Weaving the claim web. The Semantic Web: Research and Applications. 2007, Berlin \/ Heidelberg: Springer, 197-210."},{"key":"127_CR11","first-page":"80","volume-title":"The Semantic Web: Research and Applications, Volume 5021 of Lecture Notes in Computer Science","author":"T Groza","year":"2008","unstructured":"Groza T, Handschuh S, M\u00f6ller K, Decker S: KonneX-SALT: first steps towards a semantic claim federation infrastructure. The Semantic Web: Research and Applications, Volume 5021 of Lecture Notes in Computer Science. Edited by: Bechhofer S, Hauswirth M, Hoffmann J, Koubarakis M. 2008, Berlin \/ Heidelberg: Springer, 80-94. [http:\/\/dx.doi.org\/10.1007\/978-3-540-68234-9_9]"},{"issue":"null","key":"127_CR12","first-page":"1","volume":"14","author":"MS Marshall","year":"2012","unstructured":"Marshall MS, Boyce R, Deus HF, Zhao J, Willighagen EL, Samwald M, Pichler E, Hajagos J, Prud\u2019hommeaux E, Stephens S: Emerging practices for mapping and linking life sciences data using RDF \u2014 A case series. Web Semantics Science Services and Agents on the World Wide Web. 2012, 14 (null): 1-12. [http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1570826812000376]","journal-title":"Web Semantics Science Services and Agents on the World Wide Web"},{"key":"127_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2200\/S00334ED1V01Y201102WBE001","volume":"1","author":"T Heath","year":"2011","unstructured":"Heath T, Bizer C: Linked Data: evolving the web into a global data space. Synth Lectures on the Semantic Web: Theory and Technol. 2011, 1: 1-136. 10.2200\/S00334ED1V01Y201102WBE001. [http:\/\/www.morganclaypool.com\/doi\/abs\/10.2200\/S00334ED1V01Y201102WBE001]","journal-title":"Synth Lectures on the Semantic Web: Theory and Technol"},{"issue":"10","key":"127_CR14","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1345\/aph.1R150","volume":"46","author":"RD Boyce","year":"2012","unstructured":"Boyce RD, Collins C, Clayton M, Kloke J, Horn JR: Inhibitory metabolic drug interactions with newer psychotropic drugs: inclusion in package inserts and influences of concurrence in drug interaction screening software. Ann Pharmacotherapy. 2012, 46 (10): 1287-98. 10.1345\/aph.1R150. [http:\/\/www.theannals.com\/content\/early\/2012\/10\/02\/aph.1R150]","journal-title":"Ann Pharmacotherapy"},{"key":"127_CR15","volume-title":"LinkedCT: a linked data space for clinical trials","author":"O Hassanzadeh","year":"2009","unstructured":"Hassanzadeh O, Kementsietsidis A, Lim L, Miller R, Wang M: LinkedCT: a linked data space for clinical trials. 2009, [http:\/\/arxiv.org\/abs\/0908.0567]"},{"key":"127_CR16","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1758-2946-3-19","volume":"3","author":"M Samwald","year":"2011","unstructured":"Samwald M, Jentzsch A, Bouton C, Kalles\u00f8e C, Willighagen E, Hajagos J, Marshall M, Prud\u2019hommeaux E, Hassanzadeh O, Pichler E, Stephens S: Linked open drug data for pharmaceutical research and development. J Cheminformatics. 2011, 3: 19-10.1186\/1758-2946-3-19. [http:\/\/www.jcheminf.com\/content\/3\/1\/19\/abstract]","journal-title":"J Cheminformatics"},{"issue":"Pt 1","key":"127_CR17","first-page":"477","volume":"107","author":"SH Brown","year":"2004","unstructured":"Brown SH, Elkin PL, Rosenbloom ST, Husser C, Bauer BA, Lincoln MJ, Carter J, Erlbaum M, Tuttle MS: VA National Drug File Reference Terminology: a cross-institutional content coverage study. Stud health technol informatics. 2004, 107 (Pt 1): 477-481. [PMID: 15360858]","journal-title":"Stud health technol informatics"},{"key":"127_CR18","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/clpt.2009.198","volume":"87","author":"E Olvey","year":"2010","unstructured":"Olvey E, Clauschee S, Malone D: Comparison of critical drug-drug interaction listings: the Department of Veterans Affairs medical system and standard reference compendia. Clin Pharmacol Ther. 2010, 87: 48-51. 10.1038\/clpt.2009.198. [http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19890252]. [PMID: 19890252]","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"127_CR19","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1016\/j.jbi.2009.05.010","volume":"42","author":"R Boyce","year":"2009","unstructured":"Boyce R, Collins C, Horn J, Kalet I: Computing with evidence Part II: An evidential approach to predicting metabolic drug-drug interactions. J Biomed Informatics. 2009, 42 (6): 990-1003. 10.1016\/j.jbi.2009.05.010. [http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19539050]. [PMID: 19539050]","journal-title":"J Biomed Informatics"},{"issue":"7","key":"127_CR20","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1093\/bioinformatics\/bts071","volume":"28","author":"M Liakata","year":"2012","unstructured":"Liakata M, Saha S, Dobnik S, Batchelor C, D RS: Automatic recognition of conceptualisation zones in scientific articles and two life science applications. Bioinformatics. 2012, 28 (7): 991-1000. 10.1093\/bioinformatics\/bts071.","journal-title":"Bioinformatics"},{"key":"127_CR21","doi-asserted-by":"publisher","first-page":"159","DOI":"10.2307\/2529310","volume":"33","author":"JR Landis","year":"1977","unstructured":"Landis JR, Koch GG, The measurement of observer agreement for categorical data: Biometrics. 1977, 33: 159-174. 10.2307\/2529310. [http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/843571]. [PMID: 843571]","journal-title":"Biometrics"},{"issue":"8","key":"127_CR22","first-page":"1102","volume":"29","author":"L von Moltke","year":"2001","unstructured":"von Moltke L, Greenblatt D, Giancarlo G, Granda B, Harmatz J, Shader R: Escitalopram (S-citalopram) and its metabolites in vitro: cytochromes mediating biotransformation, inhibitory effects, and comparison to R-citalopram. Drug Metabol Dispos: Biol Fate Chem. 2001, 29 (8): 1102-1109. [http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11454728]. [PMID: 11454728]","journal-title":"Drug Metabol Dispos: Biol Fate Chem"},{"key":"127_CR23","volume-title":"FDA-Approved Drug Product Labeling","author":"Forest Pharmaceuticals","year":"2009","unstructured":"Forest Pharmaceuticals: Lexapro (escitalopram) tablets\/oral solution. FDA-Approved Drug Product Labeling. 2009"},{"key":"127_CR24","volume-title":"FDA Guideline: Drug Interaction Studies \u2014 Study Design, Data Analysis, and Implications for Dosing and Labeling","author":"FDA","year":"2006","unstructured":"FDA: FDA Guideline: Drug Interaction Studies \u2014 Study Design, Data Analysis, and Implications for Dosing and Labeling. 2006, Rockville, MD: Food and Drug Administration, [http:\/\/www.fda.gov\/downloads\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/ucm072101.pdf]. [Last Accessed: 03\/31\/2010]"},{"key":"127_CR25","volume-title":"FDA-Approved Drug Product Labeling","author":"Sanofi-Aventis","year":"2010","unstructured":"Sanofi-Aventis: RIFADIN (rifampin) capsule; RIFADIN IV (rifampin) injection, powder, lyophilized, for solution. FDA-Approved Drug Product Labeling. 2010"},{"issue":"10","key":"127_CR26","doi-asserted-by":"publisher","first-page":"941","DOI":"10.2146\/ajhp100440","volume":"68","author":"LE Hines","year":"2011","unstructured":"Hines LE, Murphy JE, Grizzle AJ, Malone DC: Critical issues associated with drug\u2013drug interactions: Highlights of a multistakeholder conference. Am J Health-Syst Pharmacy. 2011, 68 (10): 941-946. 10.2146\/ajhp100440. [http:\/\/www.ajhp.org\/content\/68\/10\/941.short]","journal-title":"Am J Health-Syst Pharmacy"},{"issue":"6","key":"127_CR27","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/j.jbi.2009.05.001","volume":"42","author":"R Boyce","year":"2009","unstructured":"Boyce R, Collins C, Horn J, Kalet I: Computing with evidence Part I: A drug-mechanism evidence taxonomy oriented toward confidence assignment. J Biomed Inform. 2009, 42 (6): 979-989. 10.1016\/j.jbi.2009.05.001.","journal-title":"J Biomed Inform"},{"issue":"2","key":"127_CR28","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.14778\/1687553.1687599","volume":"2","author":"O Hassanzadeh","year":"2009","unstructured":"Hassanzadeh O, Xin R, Miller R, Kementsietsidis A, Lim L, Wang M: Linkage query writer. Proc VLDB Endowment. 2009, 2 (2): 1590-1593.","journal-title":"Proc VLDB Endowment"},{"key":"127_CR29","volume-title":"Advancing Regulatory Science at FDA","author":"FDA","year":"2011","unstructured":"FDA: Advancing Regulatory Science at FDA. 2011, Rockville, MD: Food and Drug Administration, [http:\/\/www.fda.gov\/downloads\/ScienceResearch\/SpecialTopics\/RegulatoryScience\/UCM268225.pdf]. [Last Accessed: 10\/31\/2012]"},{"key":"127_CR30","volume-title":"FDA-approved drug product labeling","author":"Medi-Physics Inc","year":"2011","unstructured":"Medi-Physics Inc: DATSCAN (ioflupane i-123 and iodine) injection, solution. FDA-approved drug product labeling. 2011"},{"key":"127_CR31","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1093\/bib\/6.1.57","volume":"6","author":"AM Cohen","year":"2005","unstructured":"Cohen AM, Hersh W: A survey of current work in biomedical text a survey of current work in biomedical text mining. Briefings in Bioinf. 2005, 6: 57-71. 10.1093\/bib\/6.1.57.","journal-title":"Briefings in Bioinf"},{"issue":"7","key":"127_CR32","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.tibtech.2010.04.005","volume":"28","author":"S Ananiadou","year":"2010","unstructured":"Ananiadou S, Tsujii J, S P: Event extraction for systems biology by text mining the literature. Trends Biotechnol. 2010, 28 (7): 381-390. 10.1016\/j.tibtech.2010.04.005.","journal-title":"Trends Biotechnol"},{"issue":"10","key":"127_CR33","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1001\/archinternmed.2011.182","volume":"171","author":"JFJ Duke","year":"2011","unstructured":"Duke JFJ: A quantitative analysis of adverse events and \u201coverwarning\u201d in drug labeling. Arch Internal Med. 2011, 171 (10): 941-954. [http:\/\/dx.doi.org\/10.1001\/archinternmed.2011.182]","journal-title":"Arch Internal Med"},{"key":"127_CR34","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/msb.2009.98","volume":"6","author":"M Kuhn","year":"2010","unstructured":"Kuhn M, Campillos M, Letunic I, Jensen LJ, Bork P: A side effect resource to capture phenotypic effects of drugs. Mol Syst Biol. 2010, 6: 343-[PMID: 20087340]","journal-title":"Mol Syst Biol"},{"key":"127_CR35","first-page":"206","volume-title":"BioNLP: Proceedings of the 2012 Workshop on Biomedical Natural Language Processing","author":"R Boyce","year":"2012","unstructured":"Boyce R, Gardner G, Harkema H: Using natural language processing to extract drug-drug interaction information from package inserts. BioNLP: Proceedings of the 2012 Workshop on Biomedical Natural Language Processing. 2012, Montr\u00e9al, Canada: Association for Computational Linguistics, 206-213. [http:\/\/www.aclweb.org\/anthology\/W12-2426]"},{"issue":"11","key":"127_CR36","doi-asserted-by":"publisher","first-page":"2977","DOI":"10.1021\/ci200367w","volume":"51","author":"M Takarabe","year":"2011","unstructured":"Takarabe M, Shigemizu D, Kotera M, Goto S, Kanehisa M: Network-based analysis and characterization of adverse drug\u00e2\u0102\u015edrug interactions. J Chem Inf Model. 2011, 51 (11): 2977-2985. 10.1021\/ci200367w. [http:\/\/dx.doi.org\/10.1021\/ci200367w]","journal-title":"J Chem Inf Model"},{"issue":"2","key":"127_CR37","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.jbi.2011.10.012","volume":"45","author":"S Rubrichi","year":"2012","unstructured":"Rubrichi S, Quaglini S: Summary of Product Characteristics content extraction for a safe drugs usage. J Biomed Informatics. 2012, 45 (2): 231-239. 10.1016\/j.jbi.2011.10.012. [http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22094356]. [PMID: 22094356]","journal-title":"J Biomed Informatics"},{"issue":"Suppl 5","key":"127_CR38","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1471-2105-11-S5-P9","volume":"11","author":"I Segura-Bedmar","year":"2010","unstructured":"Segura-Bedmar I, Martinez P, de Pablo-Sanchez C: Extracting drug-drug interactions from biomedical texts. BMC Bioinf. 2010, 11 (Suppl 5): 9-10.1186\/1471-2105-11-S5-P9.","journal-title":"BMC Bioinf"},{"key":"127_CR39","volume-title":"Proceedings of the First Challenge Task: Drug-Drug Interaction Extraction 2011","author":"I Segura-Bedmar","year":"2011","unstructured":"Segura-Bedmar I, Martinez P, Sanchez-Cisneros D (Eds): Proceedings of the First Challenge Task: Drug-Drug Interaction Extraction 2011. 2011, Huelva, Spain, [http:\/\/sunsite.informatik.rwth-aachen.de\/Publications\/CEUR-WS\/Vol-761\/]"},{"key":"127_CR40","first-page":"11","volume-title":"1st Challenge task on Drug-Drug Interaction Extraction (DDIExtraction 2011)","author":"P Thomas","year":"2011","unstructured":"Thomas P, Neves M, Solt I, Tikk D, Leser U: Relation extraction for drug-drug interactions using ensemble learning. 1st Challenge task on Drug-Drug Interaction Extraction (DDIExtraction 2011). 2011, Huelva, Spain, 11-18."},{"issue":"6","key":"127_CR41","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/j.jbi.2010.08.005","volume":"43","author":"A Coulet","year":"2010","unstructured":"Coulet A, Shah NH, Garten Y, Musen M, Altman RB: Using text to build semantic networks for pharmacogenomics. J Biomed Informatics. 2010, 43 (6): 1009-1019. 10.1016\/j.jbi.2010.08.005. [PMID: 20723615]","journal-title":"J Biomed Informatics"},{"key":"127_CR42","first-page":"410","volume-title":"Pac Symp Biocomputing. Pac Symp Biocomputing","author":"B Percha","year":"2012","unstructured":"Percha B, Garten Y, Altman RB: Discovery and explanation of drug-drug interactions via text mining. Pac Symp Biocomputing. Pac Symp Biocomputing. 2012, 410-421. [http:\/\/view.ncbi.nlm.nih.gov\/pubmed\/22174296]"},{"issue":"8","key":"127_CR43","doi-asserted-by":"publisher","first-page":"e1002614","DOI":"10.1371\/journal.pcbi.1002614","volume":"8","author":"JD Duke","year":"2012","unstructured":"Duke JD, Han X, Wang Z, Subhadarshini A, Karnik SD, Li X, Hall SD, Jin Y, Callaghan JT, Overhage MJ, Flockhart DA, Strother RM, Quinney SK, Li L: Literature based drug interaction prediction with clinical assessment using electronic medical records: novel myopathy associated drug interactions. PLoS Comput Biol. 2012, 8 (8): e1002614-10.1371\/journal.pcbi.1002614. [http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22912565]. [PMID: 22912565]","journal-title":"PLoS Comput Biol"},{"issue":"18","key":"127_CR44","doi-asserted-by":"publisher","first-page":"i547","DOI":"10.1093\/bioinformatics\/btq382","volume":"26","author":"L Tari","year":"2010","unstructured":"Tari L, Anwar S, Liang S, Cai J, Baral C: Discovering drug-drug interactions: a text-mining and reasoning approach based on properties of drug metabolism. Bioinformatics (Oxford, England). 2010, 26 (18): i547-553. 10.1093\/bioinformatics\/btq382. [PMID: 20823320]","journal-title":"Bioinformatics (Oxford, England)"},{"key":"127_CR45","unstructured":"FDA: Providing Regulatory Submissions in Electronic Format \u2014 Content of Labeling. Guidance for Industry UCM072331, Food and Drug Administration, Rockville, MD 2005. [http:\/\/www.fda.gov\/downloads\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/UCM072331.pdf]"},{"key":"127_CR46","volume-title":"Logical Observation Identifiers Names and Codes (LOINC\u24c7) \u2013 LOINC","author":"Inc Regenstrief Institute","year":"2012","unstructured":"Regenstrief Institute Inc: Logical Observation Identifiers Names and Codes (LOINC\u24c7) \u2013 LOINC. 2012, [http:\/\/loinc.org\/]"},{"key":"127_CR47","volume-title":"DailyMed","author":"National Library of Medicine","year":"2012","unstructured":"National Library of Medicine: DailyMed. 2012, [http:\/\/dailymed.nlm.nih.gov\/dailymed\/about.cfm]"},{"key":"127_CR48","volume-title":"The D2RQ platform \u2013 accessing relational databases as virtual RDF graphs","author":"R Cyganiak","year":"2012","unstructured":"Cyganiak R: The D2RQ platform \u2013 accessing relational databases as virtual RDF graphs. 2012, [http:\/\/d2rq.org\/]"},{"key":"127_CR49","volume-title":"Geriatric Dosage Handbook 2012: Including Clinical Recommendations and Monitoring Guidelines. Lexi Comp","author":"TP Semla","year":"2011","unstructured":"Semla TP, Beizer JL, Higbee MD (Eds): Geriatric Dosage Handbook 2012: Including Clinical Recommendations and Monitoring Guidelines. Lexi Comp. 2011"},{"issue":"7","key":"127_CR50","first-page":"9","volume":"50","author":"C Sutton","year":"2010","unstructured":"Sutton C, McCallum A: An Introduction to Conditional Random Fields. Rapport Technique MSCIS0421 Department of Computer and Information Science University of Pennsylvania. 2010, 50 (7): 9-[http:\/\/arxiv.org\/abs\/1011.4088]","journal-title":"Rapport Technique MSCIS0421 Department of Computer and Information Science University of Pennsylvania"}],"container-title":["Journal of Biomedical Semantics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/2041-1480-4-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/2041-1480-4-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/2041-1480-4-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:22:28Z","timestamp":1790036548000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/2041-1480-4-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,26]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2013,12]]}},"alternative-id":["127"],"URL":"https:\/\/doi.org\/10.1186\/2041-1480-4-5","relation":{},"ISSN":["2041-1480"],"issn-type":[{"value":"2041-1480","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,26]]},"assertion":[{"value":"27 March 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"5"}}